Examining the Sunshine Act with David Hoffmeister | Medical Device Podcast

Posted by Chris Wiltz on October 16, 2012

Will the Sunshine Act force medical device companies to lay off even more employees? Perhaps at a rate of 2-4 per year?

David Hoffmeister

Will the Sunshine Act force medical device companies to lay off even more employees? Perhaps at a rate of 2-4 per year?

Let’s do some simple math: It’s estimated that compliance with the Sunshine Act will cost medical device companies about $200,000 annually. If the average annual salary of an employee within a medical device company is $65,000, that’s roughly three employees. Ouch.

I think the overwhelming majority of the American public would like to see more transparency between physicians and medical device companies. But are the outrageous compliance costs of the Sunshine Act worth 2-4 jobs per company per year? Better yet, once the data from the legislation is made public, will ‘Joe Patient’ even be able to interpret it?

To help answer some of these questions, enter David Hoffmeister, partner at Wilson Sonsini Goodrich & Rosati. In this interview, David provides us with actionable rules regarding physician and HCP consulting arrangements in addition to helping us understand the overall impact of the Sunshine Act on medical device companies.

Here's What You Will Learn:

  • Origin, scope, and purpose of the Sunshine Act and the problems this legislation hopes to solve.
  • Will patients be able to decipher the public data resulting from the Sunshine Act? And will they even care?
  • Resource constraints that will be forced upon medical device companies because of the Sunshine Act.
  • How will medtech startups be affected by the legislation?
  • Consequences within medical device companies if adequate policies are NOT put in place. Hint: David thinks it’s like driving a car without car insurance.
  • Policies and procedures that medical device companies need to have in place in order to comply with the Sunshine Act. We also cover the 2 exceptions.
  • Are their any loopholes in the Sunshine Act that medical device companies can exploit?
  • Importance of consistent ‘needs assessments’ pertaining to HCP consultants.
  • David’ lasting advice to medtech companies in regards to the Sunshine Act.

Click here to download audio.

Interview transcripts are available here.

Scott Nelson is a self-described medtech enthusiast, ambitious doer, and resident contrarian. In an effort to learn from drt to learn from dynamic experts in the medtech space, he founded Scott has worked for some of the largest medical device companies in the world. After plenty of wins and losses, is the site he wished he had from the beginning.

Printer-friendly version
No votes yet

Login to post comments